Using WSIC data, we will quantify CKM stage prevalence, define CKM phenotypes, assess healthcare utilisation, and evaluate adherence to key CKM therapies across NWL to support integrated, data‑driven population health planning.
This project will help the NHS understand how heart, kidney, and metabolic conditions (like diabetes) occur
together in the population. The project will also identify groups of patients at highest risk of having these
conditions, how patients use healthcare, and highlight where care (like prescribing of medications) can be
improved earlier to prevent serious illness and hospital admissions.
